CSIMarket
 


Novocure Limited  (NVCR)
Other Ticker:  
 
 

NVCR's Revenue Growth by Quarter and Year

Novocure Limited's Revenue results by quarter and year




NVCR Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 133.78 128.43 133.21 143.95
III Quarter September 127.32 131.00 133.61 132.66
II Quarter June 126.05 140.87 133.52 115.93
I Quarter March 122.18 137.55 134.70 101.83
FY   509.33 537.85 535.04 494.37



NVCR Revenue fourth quarter 2023 Y/Y Growth Comment
Novocure Limited reported Revenue growth of 4.17% year on year in the fourth quarter 2023, to $ 133.78 millions, this is lower than Novocure Limited's recent average Revenue rise of 48.74%.

Looking into fourth quarter 2023 results within Medical Equipment & Supplies industry 59 other companies have achieved higher Revenue growth. While Novocure Limited' s Revenue increase of 4.17% ranks overall at the positon no. 1191 in the fourth quarter 2023.




NVCR Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 4.17 % -3.59 % -7.46 % 45.07 %
III Quarter September -2.81 % -1.95 % 0.72 % 44.1 %
II Quarter June -10.52 % 5.5 % 15.17 % 33.7 %
I Quarter March -11.17 % 2.12 % 32.28 % 38.9 %
FY   -5.3 % 0.53 % 8.23 % 40.72 %

Financial Statements
Novocure Limited's fourth quarter 2023 Revenue $ 133.78 millions NVCR's Income Statement
Novocure Limited's fourth quarter 2022 Revenue $ 128.43 millions Quarterly NVCR's Income Statement
New: More NVCR's historic Revenue Growth >>


NVCR Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 5.08 % -1.96 % -0.3 % 8.51 %
III Quarter September 1.01 % -7.01 % 0.07 % 14.43 %
II Quarter June 3.17 % 2.41 % -0.88 % 13.85 %
I Quarter March -4.87 % 3.26 % -6.43 % 2.62 %
FY (Year on Year)   -5.3 % 0.53 % 8.23 % 40.72 %




Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #60
Healthcare Sector #164
Overall #1191

Revenue Y/Y Growth Statistics
High Average Low
304.15 % 48.74 % -7.12 %
(Jun 30 2017)  
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #60
Healthcare Sector #164
Overall #1191
Revenue Y/Y Growth Statistics
High Average Low
304.15 % 48.74 % -7.12 %
(Jun 30 2017)  

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Novocure Limited's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
39.53 % 8.36 % -7.01 %
(Dec 31 2016)  


NVCR's IV. Quarter Q/Q Revenue Comment
Novocure Limited achieved in the IV. Quarter 2023 below company average Revenue increase of 5.08% quarter on quarter, to $ 133.78 millions.

IV. Quarter 2023 NVCR's results were paradoxical, even if lower than the ordinary rise of 8.36 %, yet it demonstrates a quite acceleration compare to the -1.96% in the same quarter a year ago

Within Medical Equipment & Supplies industry 69 other companies have achieved higher Revenue quarter on quarter growth. While Novocure Limited's Revenue growth quarter on quarter, overall rank is 1025.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #70
Healthcare Sector #200
Overall #1025
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #70
Healthcare Sector #200
Overall #1025
Revenue Q/Q Growth Statistics
High Average Low
39.53 % 8.36 % -7.01 %
(Dec 31 2016)  


NVCR's IV. Quarter Q/Q Revenue Comment
Novocure Limited achieved in the IV. Quarter 2023 below company average Revenue increase of 5.08% quarter on quarter, to $ 133.78 millions.

Albeit the IV. Quarter 2023 NVCR's results were beneath the ordinary of 8.36 %, it has been yet promising sign, as the IV. Quarter improvement, outshines the -1.96% surge in the IV. Quarter a year ago

Within Medical Equipment & Supplies industry 69 other companies have achieved higher Revenue quarter on quarter growth. While Novocure Limited's Revenue growth quarter on quarter, overall rank is 1025.


Novocure Limited's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 509.34 $ 503.98 $ 507.66 $ 522.48 $ 537.84
Y / Y Revenue Growth (TTM) -5.3 % -7.12 % -6.89 % -2.86 % 0.53 %
Year on Year Revenue Growth Overall Ranking # 1121 # 178 # 198 # 2410 # 1377
Seqeuential Revenue Change (TTM) 1.06 % -0.72 % -2.84 % -2.86 % -0.88 %
Seq. Revenue Growth (TTM) Overall Ranking # 1191 # 2254 # 192 # 2461 # 1919




Cumulative Revenue growth Comment
Novocure Limited showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Novocure Limited's annual Revenue decline would be -5.3% year on year to $509 millions.

In the Healthcare sector 156 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 178 to 1121.

Revenue TTM Q/Q Growth Statistics
High Average Low
304.15 %
48.74 %
-7.12 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 60
Healthcare Sector # 157
Overall # 1121

Revenue TTM Y/Y Growth Statistics
High Average Low
304.15 %
48.74 %
-7.12 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 60
Sector # 164
S&P 500 # 1191
Cumulative Revenue growth Comment
Novocure Limited showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Novocure Limited's annual Revenue decrease would be -5.3% year on year to $509 millions.

In the Healthcare sector 156 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 178 to 1121.

Revenue TTM Q/Q Growth Statistics
High Average Low
304.15 %
48.74 %
-7.12 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 60
Healthcare Sector # 157
Overall # 1121

Revenue TTM Y/Y Growth Statistics
High Average Low
304.15 %
48.74 %
-7.12 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 60
Sector # 164
S&P 500 # 1191




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NVCR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NVCR's Competitors
Revenue Growth for Novocure Limited's Suppliers
Revenue Growth for NVCR's Customers

You may also want to know
NVCR's Annual Growth Rates NVCR's Profitability Ratios NVCR's Asset Turnover Ratio NVCR's Dividend Growth
NVCR's Roe NVCR's Valuation Ratios NVCR's Financial Strength Ratios NVCR's Dividend Payout Ratio
NVCR's Roa NVCR's Inventory Turnover Ratio NVCR's Growth Rates NVCR's Dividend Comparisons



Companies with similar Revenue decrease for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Exagen Inc 7.23%$ 7.229 millions
Chemed Corporation7.18%$ 7.182 millions
Innate Pharma Sa6.88%$ 6.878 millions
Sonoma Pharmaceuticals Inc 6.59%$ 6.590 millions
Clever Leaves Holdings Inc 6.42%$ 6.415 millions
Align Technology inc 6.16%$ 6.158 millions
Dr Reddy s Laboratories Limited5.87%$ 5.874 millions
Elanco Animal Health Inc5.50%$ 5.505 millions
Royalty Pharma Plc5.36%$ 5.359 millions
Cano Health Inc 5.27%$ 5.271 millions
Zai Lab Limited5.16%$ 5.160 millions
Ocular Therapeutix Inc 5.16%$ 5.158 millions
Tactile Systems Technology Inc 5.05%$ 5.046 millions
Ontrak Inc 5.02%$ 5.020 millions
Select Medical Holdings Corp4.89%$ 4.894 millions
Icon Plc4.89%$ 4.893 millions
Fonar Corporation4.66%$ 4.659 millions
Novocure Limited4.17%$ 4.170 millions
Owens and Minor inc4.13%$ 4.127 millions
Surgery Partners Inc 4.00%$ 4.002 millions
Lifeloc Technologies Inc 3.78%$ 3.778 millions
Teladoc Health Inc 3.58%$ 3.578 millions
Iqvia Holdings Inc 3.45%$ 3.450 millions
Castle Biosciences Inc 3.39%$ 3.387 millions
Astrazeneca Plc3.29%$ 3.292 millions
West Pharmaceutical Services Inc 3.22%$ 3.217 millions
Becton Dickinson And Company2.62%$ 2.617 millions
Cumberland Pharmaceuticals Inc2.51%$ 2.514 millions
Prestige Consumer Healthcare Inc 2.33%$ 2.328 millions
Sanofi2.32%$ 2.324 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com